Edition:
United Kingdom

XOMA Corp (XOMA.OQ)

XOMA.OQ on NASDAQ Stock Exchange Global Market

32.87USD
11 Dec 2017
Change (% chg)

$0.37 (+1.14%)
Prev Close
$32.50
Open
$32.47
Day's High
$33.37
Day's Low
$30.76
Volume
70,588
Avg. Vol
62,701
52-wk High
$34.04
52-wk Low
$3.99

Select another date:

Thu, Dec 7 2017

BRIEF-XOMA Announces Exclusive License Agreement For XOMA 358 With Rezolute Inc.

* XOMA ANNOUNCES EXCLUSIVE LICENSE AGREEMENT FOR XOMA 358 WITH REZOLUTE, INC.

BRIEF-Xoma posts Q3 revenue of $36.2 million

* Qtrly diluted net income per share available to common stockholders $1.98 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

BRIEF-XOMA ANNOUNCES MULTIPLE NEW LICENSE AGREEMENTS FOR PROPRIETARY PHAGE DISPLAY LIBRARIES

* XOMA ANNOUNCES MULTIPLE NEW LICENSE AGREEMENTS FOR PROPRIETARY PHAGE DISPLAY LIBRARIES

BRIEF-XOMA Earns $3 million milestone payment from its license agreement with Nanotherapeutics

* XOMA earns $3 million milestone payment from its license agreement with nanotherapeutics Source text for Eikon: Further company coverage: [XOMA.O ]

BRIEF-Novartis Pharma reports a 6.6 percent passive stake in Xoma Corp as of August 24, 2017

* Novartis Pharma AG reports a 6.6 percent passive stake in Xoma Corp as of august 24, 2017 - SEC filing‍​ Source text for Eikon: (http://bit.ly/2gEet2Y) Further company coverage:

BRIEF-Xoma announces transformational license agreements for gevokizumab and its IL-1 beta intellectual property portfolio

* Xoma announces transformational license agreements for gevokizumab and its IL-1 beta intellectual property portfolio

Select another date: